Correlation Between THC Therapeutics and Sunshine Biopharma
Can any of the company-specific risk be diversified away by investing in both THC Therapeutics and Sunshine Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining THC Therapeutics and Sunshine Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between THC Therapeutics and Sunshine Biopharma Warrant, you can compare the effects of market volatilities on THC Therapeutics and Sunshine Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in THC Therapeutics with a short position of Sunshine Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of THC Therapeutics and Sunshine Biopharma.
Diversification Opportunities for THC Therapeutics and Sunshine Biopharma
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between THC and Sunshine is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding THC Therapeutics and Sunshine Biopharma Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sunshine Biopharma and THC Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on THC Therapeutics are associated (or correlated) with Sunshine Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sunshine Biopharma has no effect on the direction of THC Therapeutics i.e., THC Therapeutics and Sunshine Biopharma go up and down completely randomly.
Pair Corralation between THC Therapeutics and Sunshine Biopharma
Given the investment horizon of 90 days THC Therapeutics is expected to generate 7.81 times more return on investment than Sunshine Biopharma. However, THC Therapeutics is 7.81 times more volatile than Sunshine Biopharma Warrant. It trades about 0.19 of its potential returns per unit of risk. Sunshine Biopharma Warrant is currently generating about 0.31 per unit of risk. If you would invest 0.04 in THC Therapeutics on August 28, 2024 and sell it today you would earn a total of 0.01 from holding THC Therapeutics or generate 25.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
THC Therapeutics vs. Sunshine Biopharma Warrant
Performance |
| Timeline |
| THC Therapeutics |
| Sunshine Biopharma |
THC Therapeutics and Sunshine Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with THC Therapeutics and Sunshine Biopharma
The main advantage of trading using opposite THC Therapeutics and Sunshine Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if THC Therapeutics position performs unexpectedly, Sunshine Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sunshine Biopharma will offset losses from the drop in Sunshine Biopharma's long position.| THC Therapeutics vs. Rezolute | THC Therapeutics vs. Tempest Therapeutics | THC Therapeutics vs. Forte Biosciences | THC Therapeutics vs. Dyadic International |
| Sunshine Biopharma vs. Sunshine Biopharma | Sunshine Biopharma vs. Thayer Ventures Acquisition | Sunshine Biopharma vs. Biofrontera Warrants | Sunshine Biopharma vs. Neurosense Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |